Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan

• Published in: Journal of Veterinary Medical Science Vol. 80; no. 2; pp. 382 - 386
• Main Authors: YAMANAKA, Takashi, NEMOTO, Manabu, BANNAI, Hiroshi, TSUJIMURA, Koji, MATSUMURA, Tomio, KOKADO, Hiroshi, GILDEA, Sarah, CULLINANE, Ann
• Format: Journal Article
• Language: English
• Published: Japan JAPANESE SOCIETY OF VETERINARY SCIENCE 01-02-2018; Japan Science and Technology Agency; The Japanese Society of Veterinary Science
• Subjects: Amino acid substitution; Antibody response; Antigenic drift; equine influenza vaccine; Florida sub-lineage Clade 2; Hemagglutinins; Horses; Immunization; Influenza; Neutralization; original antigenic sin; Vaccine efficacy; Vaccines; Virology; virus neutralization; Viruses; original antigenic sin; virus neutralization; Florida sub-lineage Clade 2; equine influenza vaccine
• ISSN: 0916-7250; 1347-7439
• DOI: 10.1292/jvms.17-0538

Equine influenza (EI) vaccine has been widely used. However, the causative EI virus (H3N8) undergoes continuous antigenic drift, and the vaccine strains must be periodically reviewed and if necessary, updated to maintain vaccine efficacy against circulating viruses. In 2016, the Japanese vaccine was updated by replacing the old viruses with the Florida sub-lineage Clade (Fc) 2 virus, A/equine/Yokohama/aq13/2010 (Y10). We investigated the virus neutralization (VN) antibody response to Fc2 viruses currently circulating in Europe, after booster or primary immunization with the new vaccine. These European viruses have the amino acid substitution A144V or I179V of the hemagglutinin. In horses that had previously received a primary course and bi-annual boosters with the old vaccine booster, immunization with the updated vaccine increased the VN antibody levels against the European Fc2 viruses as well as Y10. There were no significant differences in the VN titers against Y10 and the Fc2 viruses with A144V or I179V substitution in horses that had received a primary course of the updated vaccine. However, a mixed primary course where the first dose was the old vaccine and the second dose was the updated vaccine, reduced VN titers against the European viruses compared to that against Y10. In summary, the new vaccine affords horses protective level of VN titers against the Fc2 viruses carrying A144V or I179V substitution, but our results suggest that the combination of the old and new vaccines for primary immunization would not be optimum.